In the present work, we assessed whether variants in genes involved in tau pathogenesis would confer a risk of developing AD or drug-resistant TLE (nHS-TLE, HS-TLE, and TA-TLE) independently or by assuming a genetic interaction with the presence of the APOE ε4. Here, MAPT is linked to Alzheimer disease.